Fidelity Investments
ARMP icon

Fidelity Investments’s Armata Pharmaceuticals ARMP Stock Holding History

Fidelity Investments’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36K Buy
364
+342
+1,555% +$3.14K ﹤0.01% 5131
2026
Q1 		$225 Buy
+22
New +$185 ﹤0.01% 5223
2022
Q2 		– Sell
-285
Closed -$1K – 4889
2022
Q1 		$1K Buy
+285
New +$1.46K ﹤0.01% 4756

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Fidelity Investments's ARMP Position: Q2 2026 in Review

Fidelity Investments increased its Armata Pharmaceuticals (ARMP) stake by 1,555% in Q2 2026, buying an estimated $3.14K and bringing the position to 364 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #5131.

Fidelity Investments first reported a position in ARMP in Q1 2022 and has held it in 3 quarters since. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Fidelity Investments held 364 shares of Armata Pharmaceuticals worth $2.36K as of Q2 2026.
  • Fidelity Investments bought 342 Armata Pharmaceuticals shares in Q2 2026, an estimated $3.14K.
  • Armata Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5131 holding.
  • Fidelity Investments first reported a position in Armata Pharmaceuticals in Q1 2022 and has held it in 3 quarters since.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.